A-24 Solution
NDC 58264-0329
Product Information
A-24 (agrostis gigantea pollen, festuca pratensis pollen, poa pratensis pollen, dactylis glomerata pollen, phleum pratense pollen, anthoxanthum odoratum pollen, lolium perenne pollen, medicago sativa pollen, trifolium pratense pollen, solidago canadensis pollen, ambrosia acanthicarpa pollen, ambrosia psilostachya pollen, ambrosia trifida pollen, ambrosia artemisiifolia pollen, xanthium strumarium pollen, chenopodium album pollen, amaranthus retroflexus pollen, and cynodon dactylon pollen) is a UNAPPROVED HOMEOPATHIC-approved product labeled by Dna Labs, Inc.. This medication is typically used as a allergens [cs]. It is supplied as a solution for sublingual administration. This product entry covers the primary NDC 58264-0329 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 58264-0329?
What are the uses of this product?
What are Active Ingredients of this product?
- AGROSTIS GIGANTEA POLLEN 30 [hp_X]/mL
- AMARANTHUS RETROFLEXUS POLLEN 30 [hp_X]/mL
- AMBROSIA ACANTHICARPA POLLEN 30 [hp_X]/mL
- AMBROSIA ARTEMISIIFOLIA POLLEN 30 [hp_X]/mL
- AMBROSIA PSILOSTACHYA POLLEN 30 [hp_X]/mL
- AMBROSIA TRIFIDA POLLEN 30 [hp_X]/mL
- ANTHOXANTHUM ODORATUM POLLEN 30 [hp_X]/mL
- CHENOPODIUM ALBUM POLLEN 30 [hp_X]/mL
- CYNODON DACTYLON POLLEN 30 [hp_X]/mL
- DACTYLIS GLOMERATA POLLEN 30 [hp_X]/mL
- FESTUCA PRATENSIS POLLEN 30 [hp_X]/mL
- LOLIUM PERENNE POLLEN 30 [hp_X]/mL
- MEDICAGO SATIVA POLLEN 30 [hp_X]/mL
- PHLEUM PRATENSE POLLEN 30 [hp_X]/mL
- POA PRATENSIS POLLEN 30 [hp_X]/mL
- SOLIDAGO CANADENSIS POLLEN 30 [hp_X]/mL
- SORGHUM HALEPENSE POLLEN 30 [hp_X]/mL
- TRIFOLIUM PRATENSE POLLEN 30 [hp_X]/mL
- XANTHIUM STRUMARIUM POLLEN 30 [hp_X]/mL
Which are the Pharmacologic Classes of this product?
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Pollen Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Pollen - [CS]
- Standardized Pollen Allergenic Extract - [EPC] (Established Pharmacologic Class)
* Please review the full disclaimer at the bottom of this page.